Fund Holdings — Merck & Co., Inc.

Total Portfolio Value
$228.03M
Total Bought
$0
Total Sold
$0
Net Transaction
$0
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
KYMERA THERAPEUTICS INC(KYMR)772,165772,165033,69743,70519.17%+10,007
ALECTOR INC3,545,7193,545,71904,96410,4954.60%+5,531
EVAXION BIOTECH A/S1,214,1261,214,12602,9754,5652.00%+1,591
VIRIDIAN THERAPEUTICS INC(VRDN)93,41493,41401,3062,0160.88%+710
SUTRO BIOPHARMA INC(STRO)2,723,5092,723,50901,9442,3651.04%+421
LAVA THERAPEUTICS NV1,149,3451,149,34501,5171,7930.79%+276
XILIO THERAPEUTICS INC(XLO)1,483,7581,483,75801,0091,2500.55%+242
NEUPHORIA THERAPEUTICS INC10,02710,0270711180.05%+47
TUHURA BIOSCIENCES(HURA)13,95013,950031350.02%+3
CARISMA THERAPEUTICS INC1,473,2401,473,24005774040.18%-173
PERSONALIS INC(PSNL)14,044,94314,044,943092,13591,57340.16%-562
ENTRADA THERAPEUTICS INC(TRDA)1,739,7681,739,768011,69110,0914.43%-1,601
MODERNA INC(MRNA)2,308,1902,308,190063,68359,62126.15%-4,062
Page 1 of 1
Merck & Co., Inc. — 13F Holdings — Q3 2025 | TickerTrail